From: CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway
Variables | LNR | Total | P value | |
---|---|---|---|---|
Low(n = 91) | High(n = 91) | |||
Sex | ||||
Female | 38 | 44 | 82 | 0.577 |
Male | 52 | 48 | 100 | |
Age | ||||
≤ 65 | 44 | 49 | 93 | 0.555 |
> 65 | 46 | 43 | 89 | |
T Stage | ||||
T1&T2 | 22 | 9 | 31 | 0.009** |
T2&T3 | 68 | 83 | 151 | |
M stage | ||||
M0 | 37 | 47 | 84 | 0.062 |
M1 | 5 | 1 | 6 | |
Histological grade | ||||
G1&G2 | 64 | 62 | 126 | 0.501 |
G3&G4 | 24 | 29 | 53 | |
Tumor location | ||||
Head | 62 | 74 | 136 | 0.073 |
Non-head | 28 | 18 | 46 | |
Somker | ||||
No | 36 | 31 | 67 | 0.326 |
Yes | 36 | 43 | 79 | |
Alcohol history | ||||
No | 36 | 29 | 65 | 0.291 |
Yes | 46 | 52 | 98 | |
Diabetes history | ||||
No | 58 | 51 | 109 | 0.362 |
Yes | 16 | 20 | 36 | |
Chronic pancreatitis history | ||||
No | 67 | 60 | 127 | 0.65 |
Yes | 6 | 7 | 13 | |
Family history of cancer | ||||
No | 24 | 21 | 45 | 0.851 |
Yes | 34 | 32 | 66 |